Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Stem-Like Cancer Cells in a Dynamic 3D Culture System: A Model to Study Metastatic Cell Adhesion and Anti-Cancer Drugs.

Paolillo M, Colombo R, Serra M, Belvisi L, Papetti A, Ciusani E, Comincini S, Schinelli S.

Cells. 2019 Nov 13;8(11). pii: E1434. doi: 10.3390/cells8111434.

2.

Extracellular Matrix Alterations in Metastatic Processes.

Paolillo M, Schinelli S.

Int J Mol Sci. 2019 Oct 7;20(19). pii: E4947. doi: 10.3390/ijms20194947. Review.

3.

A dimeric bicyclic RGD ligand displays enhanced integrin binding affinity and strong biological effects on U-373 MG glioblastoma cells.

Sacco G, Dal Corso A, Arosio D, Belvisi L, Paolillo M, Pignataro L, Gennari C.

Org Biomol Chem. 2019 Oct 21;17(39):8913-8917. doi: 10.1039/c9ob01811e. Epub 2019 Sep 26.

PMID:
31556442
4.

A new millifluidic-based gastrointestinal platform to evaluate the effect of simulated dietary methylglyoxal intakes.

Colombo R, Paolillo M, Papetti A.

Food Funct. 2019 Jul 17;10(7):4330-4338. doi: 10.1039/c9fo00332k.

PMID:
31273366
5.

The Importance of Detail: How Differences in Ligand Structures Determine Distinct Functional Responses in Integrin αv β3.

Paladino A, Civera M, Curnis F, Paolillo M, Gennari C, Piarulli U, Corti A, Belvisi L, Colombo G.

Chemistry. 2019 Apr 23;25(23):5959-5970. doi: 10.1002/chem.201900169. Epub 2019 Mar 28.

PMID:
30811704
6.

An RGD small-molecule integrin antagonist induces detachment-mediated anoikis in glioma cancer stem cells.

Paolillo M, Galiazzo MC, Daga A, Ciusani E, Serra M, Colombo L, Schinelli S.

Int J Oncol. 2018 Dec;53(6):2683-2694. doi: 10.3892/ijo.2018.4583. Epub 2018 Oct 3.

PMID:
30280197
7.

Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents.

Rui M, Rossino G, Coniglio S, Monteleone S, Scuteri A, Malacrida A, Rossi D, Catenacci L, Sorrenti M, Paolillo M, Curti D, Venturini L, Schepmann D, Wünsch B, Liedl KR, Cavaletti G, Pace V, Urban E, Collina S.

Eur J Med Chem. 2018 Oct 5;158:353-370. doi: 10.1016/j.ejmech.2018.09.010. Epub 2018 Sep 8.

PMID:
30223122
8.

Sigma Receptors as Endoplasmic Reticulum Stress "Gatekeepers" and their Modulators as Emerging New Weapons in the Fight Against Cancer.

Tesei A, Cortesi M, Zamagni A, Arienti C, Pignatta S, Zanoni M, Paolillo M, Curti D, Rui M, Rossi D, Collina S.

Front Pharmacol. 2018 Jul 10;9:711. doi: 10.3389/fphar.2018.00711. eCollection 2018. Review.

9.

Glioblastoma under Siege: An Overview of Current Therapeutic Strategies.

Paolillo M, Boselli C, Schinelli S.

Brain Sci. 2018 Jan 16;8(1). pii: E15. doi: 10.3390/brainsci8010015. Review.

10.

Integrins and Exosomes, a Dangerous Liaison in Cancer Progression.

Paolillo M, Schinelli S.

Cancers (Basel). 2017 Jul 26;9(8). pii: E95. doi: 10.3390/cancers9080095. Review.

11.

Synthesis and biological evaluation of new aryl-alkyl(alkenyl)-4-benzylpiperidines, novel Sigma Receptor (SR) modulators, as potential anticancer-agents.

Rui M, Rossi D, Marra A, Paolillo M, Schinelli S, Curti D, Tesei A, Cortesi M, Zamagni A, Laurini E, Pricl S, Schepmann D, Wűnsch B, Urban E, Pace V, Collina S.

Eur J Med Chem. 2016 Nov 29;124:649-665. doi: 10.1016/j.ejmech.2016.08.067. Epub 2016 Aug 31.

PMID:
27614411
12.

Integrins in glioblastoma: Still an attractive target?

Paolillo M, Serra M, Schinelli S.

Pharmacol Res. 2016 Nov;113(Pt A):55-61. doi: 10.1016/j.phrs.2016.08.004. Epub 2016 Aug 3. Review.

PMID:
27498157
13.

Cyclic isoDGR and RGD peptidomimetics containing bifunctional diketopiperazine scaffolds are integrin antagonists.

Panzeri S, Zanella S, Arosio D, Vahdati L, Dal Corso A, Pignataro L, Paolillo M, Schinelli S, Belvisi L, Gennari C, Piarulli U.

Chemistry. 2015 Apr 13;21(16):6265-71. doi: 10.1002/chem.201406567. Epub 2015 Mar 11.

PMID:
25761230
14.

Isolation and characterization of the alkaloid Nitidine responsible for the traditional use of Phyllanthus muellerianus (Kuntze) Excell stem bark against bacterial infections.

Cesari I, Grisoli P, Paolillo M, Milanese C, Massolini G, Brusotti G.

J Pharm Biomed Anal. 2015 Feb;105:115-20. doi: 10.1016/j.jpba.2014.11.051. Epub 2014 Dec 10.

PMID:
25546028
15.

Effects of a novel cyclic RGD peptidomimetic on cell proliferation, migration and angiogenic activity in human endothelial cells.

Fanelli R, Schembri L, Piarulli U, Pinoli M, Rasini E, Paolillo M, Galiazzo MC, Cosentino M, Marino F.

Vasc Cell. 2014 May 21;6:11. doi: 10.1186/2045-824X-6-11. eCollection 2014.

16.

A small-molecule RGD-integrin antagonist inhibits cell adhesion, cell migration and induces anoikis in glioblastoma cells.

Russo MA, Paolillo M, Sanchez-Hernandez Y, Curti D, Ciusani E, Serra M, Colombo L, Schinelli S.

Int J Oncol. 2013 Jan;42(1):83-92. doi: 10.3892/ijo.2012.1708. Epub 2012 Nov 20.

17.

Endothelin B receptor antagonists block proliferation and induce apoptosis in glioma cells.

Paolillo M, Russo MA, Curti D, Lanni C, Schinelli S.

Pharmacol Res. 2010 Apr;61(4):306-15. doi: 10.1016/j.phrs.2009.11.003. Epub 2009 Nov 18.

PMID:
19931393
18.

Small molecule integrin antagonists in cancer therapy.

Paolillo M, Russo MA, Serra M, Colombo L, Schinelli S.

Mini Rev Med Chem. 2009 Oct;9(12):1439-46. Review.

PMID:
19929817
19.

Gene expression analysis of an EGFR indirectly related pathway identified PTEN and MMP9 as reliable diagnostic markers for human glial tumor specimens.

Comincini S, Paolillo M, Barbieri G, Palumbo S, Sbalchiero E, Azzalin A, Russo MA, Schinelli S.

J Biomed Biotechnol. 2009;2009:924565. doi: 10.1155/2009/924565. Epub 2009 Jul 30.

20.

Expression of endothelins and their receptors in glioblastoma cell lines.

Paolillo M, Barbieri A, Zanassi P, Schinelli S.

J Neurooncol. 2006 Aug;79(1):1-7. Epub 2006 Mar 24.

PMID:
16557350

Supplemental Content

Loading ...
Support Center